Physician

Steven G Dunder, MD

According to 2025 Medicare claims, Steven Dunder, MD (NPI: 1346264546) practices hematology/oncology in the Lincoln, NE market, with the plurality of this provider's patient population coming from Lancaster, NE. This provider's primary affiliated billing organization is CANCER PARTNERS OF NEBRASKA PC (NPI: 1437111408; TIN: 911862785) and primary practice location at 68516-5587. Dunder is affiliated with the NPG Health Collaborative LLC (ACO ID: A3287) and Bryan Health Connect ACO, LLC (ACO ID: A4573), participating under the MSSP model.

Dunder's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 967 traditional Medicare patients, billed 162,559 HCPCS/CPT codes, and received $2,687,119 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,154 prescription claims across 198 beneficiaries totaling $3,423,055 in drug costs, led by Revlimid (Lenalidomide). DME data shows 22 claims. Open Payments data shows 146 records totaling $45,560. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $1,371,246 to $3,423,055. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $15,937 to $9,241.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	975	162,720	$2,224,365
2016	995	124,434	$2,272,626
2017	1,128	134,351	$2,183,634
2018	974	141,961	$2,273,431
2019	1,197	174,216	$3,175,566
2020	1,165	222,491	$3,879,045
2021	1,173	222,140	$3,578,032
2022	1,100	211,553	$3,147,178
2023	1,145	196,689	$3,175,643
2024	967	162,559	$2,687,119

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	192	1,323	$1,371,246
2016	197	1,257	$1,374,671
2017	171	985	$971,570
2018	162	967	$1,820,111
2019	183	1,162	$2,156,727
2020	182	1,126	$2,736,462
2021	167	887	$2,451,818
2022	170	984	$2,654,586
2023	176	1,005	$2,791,829
2024	198	1,154	$3,423,055

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	28	263	$62,188
2016	N/R	180	$44,623
2017	N/R	40	$13,134
2018	N/R	58	$5,687
2019	N/R	54	$1,257
2020	N/R	22	$1,591
2021	N/R	11	$622
2022	N/R	14	$772
2023	15	54	$3,145
2024	17	22	$1,561

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	298	707	$88
80053	Blood test, comprehensive group of blood chemicals	519	945	$10
36415	Insertion of needle into vein for collection of blood sample	551	1,030	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	619	1,293	$8
83615	Lactate dehydrogenase (enzyme) level	338	614	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Revlimid	Lenalidomide	52	1,449	$892,573
Jakafi	Ruxolitinib Phosphate	27	810	$442,424
Tagrisso	Osimertinib Mesylate	24	720	$380,213
Verzenio	Abemaciclib	20	560	$282,775
Lenalidomide	Lenalidomide	23	539	$192,500

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
L8000	Breast prosthesis, mastectomy bra, without integrated breast prosthesis form, any size, any type	N	17	22	$1,561

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	143	$2,326	PFIZER INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	3	$43,234	Mirati Therapeutics, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Steven G. Dunder, MD?

Tedicare shows public-source Medicare data for Steven G. Dunder, MD (NPI 1346264546), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Steven G. Dunder, MD have ACO affiliation data?

Steven G. Dunder, MD is shown with ACO affiliation data for NPG Health Collaborative LLC (MSSP, ACO ID A3287) and Bryan Health Connect ACO, LLC (MSSP, ACO ID A4573).

What billing organization is linked to Steven G. Dunder, MD?

Steven G. Dunder, MD is linked to CANCER PARTNERS OF NEBRASKA PC (billing NPI 1437111408) in the available physician profile data.

Does Steven G. Dunder, MD have Open Payments data?

Steven G. Dunder, MD has 146 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.